Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CV9103 in Advanced or Metastatic Hormone Refractory Prostate Cancer
NCT00906243Phase 2Terminated
- Sponsor
- University of Florida
- Start
- May 2009
- Primary completion
- Dec 2010
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of CV9103 in prostate cancer (PCa), sponsored by University of Florida. Started May 2009; status: terminated.
02
Drugs
CV9103
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00906243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00906243.